These outcomes, together with a earlier report showing that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like behavior in mice,2 help the thought of targeting ACKR3 as a unique method to modulate the opioid system, which could open new therapeutic avenues for opioid-associated Diseas